Haematomyelia following warfarin therapy
Liebeschuetz, S.; Baddeley, H.; Thomas, D.J.
British Journal of Clinical Practice 48(2): 105-106
1994
ISSN/ISBN: 0007-0947 PMID: 8024983 Document Number: 438029
Document emailed within 1 workday
Related Documents
Carroll, W.E.; Jackson, R.D. 1999: Modified anticoagulant therapy factor and international normalized ratio in patients in an unstable coagulation state with respect to warfarin therapy Research Communications in Molecular Pathology and Pharmacology 105(3): 262-270Scott, E.A.; Sandler, G.A.; Byars, T.D. 1978: Warfarin: effects of intravenous loading doses and vitamin K on warfarin anticoagulation in the pony American Journal of Veterinary Research 39(12): 1888-1891
Koefoed, B.G.; Feddersen, C.; Gulløv, A.L.; Petersen, P. 1997: Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation Thrombosis and Haemostasis 77(5): 845-848
Kulkarni, V.; Bhave, A.; Munshi, R.K.; Bhalerao, S.; Bhattad, D.; Khude, S.; Upase, D. 2013: Warfarin therapy--why one dose does not fit all! Journal of the Association of Physicians of India 61(8): 571-573
Bradlow, B.A. 1983: Warfarin therapy--a practical guide South African Medical Journal 64(9): 317-319
Elliot, M.S.; Immelman, E.J.; Jeffery, P.; Benatar, S.R.; Funston, M.R.; Smith, J.A.; Jacobs, P.; Shepstone, B.J.; Ferguson, A.D.; Louw, J.H. 1978: Skin necrosis after warfarin therapy South African Medical Journal 54(15): 609-610
Kostka, R.; Havlůj, L.; Jirava, D.; Novák, L.; Vach, B.; Weiss, J. 2010: Hemorrhagic complications of warfarin therapy Rozhledy V Chirurgii: Mesicnik Ceskoslovenske Chirurgicke Spolecnosti 89(2): 124-129
Carter, B.L. 1991: Therapy of acute thromboembolism with heparin and warfarin Clinical Pharmacy 10(7): 503-518
Brooks, B.J.; Mocklin, K.E. 1981: Retropharyngeal hematoma as a complication of warfarin therapy Journal of the Louisiana State Medical Society: Official Organ of the Louisiana State Medical Society 133(10): 156-157
Ebell, M.H. 1999: Determining the risk of bleeding in warfarin therapy Journal of Family Practice 48(6): 413
Lu, W.Jessie.; Miller, N.J. 2017: Point-Counterpoint: Genotype-Guided Warfarin Therapy South Dakota medicine: the journal of the South Dakota State Medical Association 70(2): 54-56
Guthmann, R.A. 2004: Which patients with atrial fibrillation do not need anticoagulation therapy with warfarin? American Family Physician 70(5): 917-918
Squizzato, A.; Steidl, L.; Ageno, W. 2005: Current issues in the initial phase of warfarin therapy Recenti Progressi in Medicina 96(12): 612-615
Hamby, L.; Weeks, W.B.; Malikowski, C. 2000: Complications of warfarin therapy: causes, costs, and the role of the anticoagulation clinic Effective Clinical Practice: Ecp 3(4): 179-184
Ebell, M.H. 2005: Choosing between warfarin (Coumadin) and aspirin therapy for patients with atrial fibrillation American Family Physician 71(12): 2348-2350
Liu, Y.; Zhong, S.-l.; Tan, H.-h.; Yang, M.; Fei, H.-w.; Yu, X.-y.; Lin, S.-g. 2011: Impact of CYP2C9 and VKORC1 polymorphism on warfarin response during initiation of therapy Zhonghua Xin Xue Guan Bing Za Zhi 39(10): 929-935
Mikheeva, I.A.; Kropacheva, E.S.; Ignat'ev, I.V.; Bulytova, I.M.; Ramenskaia, G.V.; Sychev, D.A.; Dobrovol'skiĭ, A.B.; Panchenko, E.P. 2008: Cytochrome P4502C9(CYP2C9) gene polymorphism and safety of therapy with warfarin Kardiologiia 48(3): 52-57
Samardzija, M.; Topić, E.; Stefanović, M.; Zibar, L.; Samardzija, G.; Balen, S.; Vcev, A.; Domanović, D.; Mirat, J.; Barbić, J. 2008: Association of CYP2C9 gene polymorphism with bleeding as a complication of warfarin therapy Collegium Antropologicum 32(2): 557-564
Kinzner, C.L. 1998: Warfarin sodium (Coumadin) anticoagulant Therapy for vascular access patency Anna Journal 25(2): 195-203; Quiz 204, 209
Pattacini, C.; Manotti, C.; Pini, M.; Quintavalla, R.; Dettori, A.G. 1994: A comparative study on the quality of oral anticoagulant therapy (warfarin versus acenocoumarol) Thrombosis and Haemostasis 71(2): 188-191